Myths vs facts: ACTN3 and allergy

Claims linking the ACTN3 gene (often called the 'speed gene') to allergies are not supported by solid scientific evidence. ACTN3 encodes alpha-actinin-3, a muscle protein primarily associated with sprint and power performance. The well-studied R577X variant affects muscle fiber composition, not immune function or allergic responses. While a few early candidate-gene studies suggested possible links to asthma or atopy, these findings have not been consistently replicated in large genome-wide association studies (GWAS). Effect sizes are negligible, and any reported associations likely arise from population stratification or chance. Direct-to-consumer tests that market ACTN3 for allergy risk are overstating the science. Current evidence is best described as 'unclear' or 'marketing'. Consumers should not use ACTN3 genotyping for allergy-related decisions. Robust, independent replication in diverse populations is lacking.